Acurable to Launch Revolutionary Sleep Apnoea Testing Device in the US After Securing New FDA Clearance

London, 24th May, 2023

Company news

Following a successful launch in Europe, London-based medical device company Acurable is aiming to …

Acurable raises €11m in Series A funding round

London, 3rd October 2022

Company news

Acurable, an award-winning wearable medical devices company, today announced an €11m investment as a …

AcuPebble SA100 offers automated sleep apnoea diagnosis equivalent to cardiorespiratory polygraphy

London, 26th January 2022

Company news

AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis …